10.24335/L17587
RoyaltyStat
Collaboration to develop with exclusive patent, copyrights and know-how license to promote, market and sell the 'Bexxar' trademarked compound that is a B1 Murine antibody conjugated or not with Iodine137 and other anti-CD20 monoclonal antibody in pharmaceutical products for the treatment, prevention or palliation of any indication in humans, including relapsed or refractory or first line low and intermediate grade non-Hodgkin's lymphoma, chronic lymphocytic leukemia, multiple myeloma, and bone marrow transplant preparation.
RoyaltyStat
1998